<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25378991</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1226-8453</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of ginseng research</Title><ISOAbbreviation>J Ginseng Res</ISOAbbreviation></Journal><ArticleTitle>Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3.</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>179</EndPage><MedlinePgn>173-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jgr.2014.04.003</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ginsenosides are the major components responsible for the biochemical and pharmacological actions of ginseng, and have been shown to have various biological activities. In this study, we investigated the antiviral activities of seven ginsenosides [protopanaxatriol (PT) type: Re, Rf, and Rg2; protopanaxadiol (PD) type: Rb1, Rb2, Rc, and Rd)] against coxsackievirus B3 (CVB3), enterovirus 71 (EV71), and human rhinovirus 3 (HRV3).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Assays of antiviral activity and cytotoxicity were evaluated by the sulforhodamine B method using the cytopathic effect (CPE) reduction assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The antiviral assays demonstrated that, of the seven ginsenosides, the PT-type ginsenosides (Re, Rf, and Rg2) possess significant antiviral activities against CVB3 and HRV3 at a concentration of 100 &#x3bc;g/mL. Among the PT-type ginsenosides, only ginsenoside Rg2 showed significant anti-EV71 activity with no cytotoxicity to cells at 100 &#x3bc;g/mL. The PD-type ginsenosides (Rb1, Rb2, Rc, and Rd), by contrast, did not show any significant antiviral activity against CVB3, EV71, and HRV3, and exhibited cytotoxic effects to virus-infected cells. Notably, the antiviral efficacies of PT-type ginsenosides were comparable to those of ribavirin, a commonly used antiviral drug.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Collectively, our findings suggest that the ginsenosides Re, Rf, and Rg2 have the potential to be effective in the treatment of CVB3, EV71, and HRV3 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jae-Hyoung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hwa-Jung</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Beauty Science, Kwangju Women's University, Gwangju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Hyuk-Hwan</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Natural Medicine Research Center, Korea Research Institute Bioscience and Biotechnology, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Eun-Hye</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bo-Ra</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Sei-Ryang</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Natural Medicine Research Center, Korea Research Institute Bioscience and Biotechnology, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Kwangman</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Targeted Medicine Research Center, Korea Research Institute Bioscience and Biotechnology, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Sang-Gu</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yong-Pyo</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sungchan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Targeted Medicine Research Center, Korea Research Institute Bioscience and Biotechnology, Chungcheongbuk-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Hyun-Jeong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Ginseng Res</MedlineTA><NlmUniqueID>100890690</NlmUniqueID><ISSNLinking>1226-8453</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVB3</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">HRV3</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">ginsenosides</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25378991</ArticleId><ArticleId IdType="pmc">PMC4213867</ArticleId><ArticleId IdType="doi">10.1016/j.jgr.2014.04.003</ArticleId><ArticleId IdType="pii">S1226-8453(14)00054-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whitton J.L., Cornell C.T., Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol. 2005;3:765&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., Vasilenko S., Brodvarova I., Nikolova M., Gyurova S. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;6:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Lei H.Y., Huang K.J., Wu J.M., Wang J.R., Yu C.K., Su I.J., Liu C.C. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J&#xa0;Infect Dis. 2003;188:564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Yeo S.G., Hong E.H., Lee B.R., Kim J.W., Kim J., Jeong H., Kwon Y., Kim H., Lee S. Antiviral activity of Hederasaponin B from Hedera helix against Enterovirus 71 subgenotypes C3 and C4a. Biomol Ther. 2014;22:41&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3936428</ArticleId><ArticleId IdType="pubmed">24596620</ArticleId></ArticleIdList></Reference><Reference><Citation>Makela M.J., Puhakka T., Ruuskanen O., Leinonen M., Saikku P., Kimpimaki M., Blomqvist S., Hyypia T., Arstila P. Viruses and bacteria in the etiology of the common cold. J&#xa0;Clin Microbiol. 1998;36:539&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104573</ArticleId><ArticleId IdType="pubmed">9466772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Message S.D., Qiu Y., Mallia P., Kebadze T., Contoli M., Ward C.K., Barnathan E.S., Mascelli M.A., Kon O.M. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest. 2014;156:1219&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4042510</ArticleId><ArticleId IdType="pubmed">24457412</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner R.B. The treatment of rhinovirus infections: progress and potential. Antiviral Res. 2001;49:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125581</ArticleId><ArticleId IdType="pubmed">11166856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlietinck A.J., Vanden Berghe D.A. Can ethnopharmacology contribute to the development of antiviral drugs? J&#xa0;Ethnopharmacol. 1991;32:141&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">1652667</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan M.M. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88925</ArticleId><ArticleId IdType="pubmed">10515903</ArticleId></ArticleIdList></Reference><Reference><Citation>Briskin D.P. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol. 2000;124:507&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1539282</ArticleId><ArticleId IdType="pubmed">11027701</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.E. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev. 2001;6:567&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassim S.A., Naji M.A. Novel antiviral agents: a medicinal plant perspective. J&#xa0;Appl Microbiol. 2003;95:412&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">12911688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuzzati N. Analysis methods of ginsenosides. J&#xa0;Chromatogr B Analyt Technol Biomed Life Sci. 2004;812:119&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">15556492</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X., Chen J., Sakwiwatkul K., Li R., Hu S. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Int Immunopharmacol. 2010;10:351&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">20034596</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng D., Wang H., Qu C., Xie L., Wicks S.M., Xie J. Ginsenoside Re: its chemistry, metabolism and pharmacokinetics. Chin Med. 2012 Feb 7;7:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296575</ArticleId><ArticleId IdType="pubmed">22314249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae S., Kang K.A., Chang W.Y., Kim M.J., Lee S.J., Lee Y.S., Kim H.S., Kim D.H., Hyun J.W. Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J&#xa0;Agric Food Chem. 2009;57:5777&#x2013;5782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19526988</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho W.C., Chung W.S., Lee S.K., Leung A.W., Cheng C.H., Yue K.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550:173&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">17027742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.S. Korean red ginseng tonic extends lifespan in D.&#xa0;melanogaster. Biomol Ther. 2013;21:241&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830124</ArticleId><ArticleId IdType="pubmed">24265871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Rayburn E.R., Hao M., Zhao Y., Hill D.L., Zhang R., Wang H. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate. 2008;68:809&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">18324646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Lee B.H., Jung J.Y., Cheon D.S., Kim K.T., Choi C. Antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus. J&#xa0;Ginseng Res. 2011;35:429&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659551</ArticleId><ArticleId IdType="pubmed">23717088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang L.J., Choi Y.J., Lee S.G. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol. 2013;45:2612&#x2013;2621.</Citation><ArticleIdList><ArticleId IdType="pubmed">24004833</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.J., Kim J.H., Lee C.H., Ahn Y.J., Song J.H., Baek S.H., Kwon D.H. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 2009;81:77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114206</ArticleId><ArticleId IdType="pubmed">18992773</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun T.K. Brief introduction of Panax ginseng C.A. Meyer. J&#xa0;Korean Med Sci. 2001;16:S3&#x2013;S5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202213</ArticleId><ArticleId IdType="pubmed">11748372</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera E., Ekholm Pettersson F., Inganas M., Paulie S., Gronvik K.O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine. 2005;23:5411&#x2013;5419.</Citation><ArticleIdList><ArticleId IdType="pubmed">16286158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo Y.C., Lee J., Park S.R., Nam K.Y., Cho Y.H., Choi J.E. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J&#xa0;Ginseng Res. 2013;37:80&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659615</ArticleId><ArticleId IdType="pubmed">23717160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Lee B.H., Lee S., Choi C. Reduction of hepatitis A virus on FRhK-4 cells treated with Korean red ginseng extract and ginsenosides. J&#xa0;Food Sci. 2013;78:M1412&#x2013;M1415.</Citation><ArticleIdList><ArticleId IdType="pubmed">23931146</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama T., Urano T., Osano M., Hayashi Y., Sekine S., Ando T., Makinom S. Outbreak of herpangina associated with Coxsackievirus B3 infection. Pediatr Infect Dis J. 1989;8:495&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">2549494</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci J.D., Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16:37&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169142</ArticleId><ArticleId IdType="pubmed">16287208</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.J., Lim C.H., Song J.H., Baek S.H., Kwon D.H. Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine. 2009;16:35&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">19097770</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.J., Song J.H., Lim C.H., Baek S.H., Kwon D.H. Anti-human rhinovirus activity of raoulic acid from Raoulia australis. J&#xa0;Med Food. 2010;13:326&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412019</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquino R., De Simone F., Pizza C., Conti C., Stein M.L. Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda. J&#xa0;Nat Prod. 1989;52:679&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">2553871</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquino R., Conti C., De Simone F., Orsi N., Pizza C., Stein M.L. Antiviral activity of constituents of Tamus communis. J&#xa0;Chemother. 1991;3:305&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">1667189</ArticleId></ArticleIdList></Reference><Reference><Citation>De Tommasi N., Conti C., Stein M.L., Pizza C. Structure and in vitro antiviral activity of triterpenoid saponins from Calendula arvensis. Planta Med. 1991;57:250&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">1654576</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber N.D., Andersen D.O., North J.A., Murray B.K., Lawson L.D., Hughes B.G. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med. 1992;58:417&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">1470664</ArticleId></ArticleIdList></Reference><Reference><Citation>Denyer C.V., Jackson P., Loakes D.M., Ellis M.R., Young D.A. Isolation of antirhinoviral sesquiterpenes from ginger (Zingiber officinale) J&#xa0;Nat Prod. 1994;57:658&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">8064299</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatthaar-Saalmuller B., Sacher F., Esperester A. Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiviral Res. 2001;50:223&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">11397509</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Fancher M.J., Felock P.J., Rossmann M.G., Miller M.S., Diana G., Treasurywala A.M., McKinlay M.A., Dutko F.J. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J&#xa0;Virol. 1989;63:2002&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250615</ArticleId><ArticleId IdType="pubmed">2539499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeichhardt H., Otto M.J., McKinlay M.A., Willingmann P., Habermehl K.O. Inhibition of poliovirus uncoating by disoxaril (WIN 51711) Virology. 1987;160:281&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">2820136</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer R., Laessig K. Safety and efficacy evaluation of pleconaril for treatment of the common cold. Clin Infect Dis. 2003;37:1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">14689362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Kang S.A., Han S.M., Shim I. Comparison of the antiobesity effects of the protopanaxadiol- and protopanaxatriol-type saponins of red ginseng. Phytother Res. 2009;23:78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">18709638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>